According to reports on Friday, the pharmaceutical company decided to stop giving its antibody-drug to coronavirus patients on ventilators or those receiving high amounts of oxygen.
However, the company has said it will continue the trial on patients with less severe bouts of the illness
This comes as another pharmaceutical company, ‘Eli Lilly,’ ended trials on hospitalized patients on Monday after the drug was determined ineffective for severe cases of the coronavirus
UK
Australia
France
Germany
Russia
India
Canada